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Abstract 
We used a modified transcranial sonography 
technique to study the cortex of the temporal 
lobe, a brain region involved in the processing of 
functions that are often compromised in Myalgic 
Encephalomyelitis/Chronic Fatigue Syndrome 
(ME/CFS) patients. We studied the meninges, the 
subarachnoidal space and the cortex. The spatial 
resolution and the ability to visualize structures of 
200-300 µm size, led us to hypothesize that the 
linear structures parallel to the subarachnoidal 
space could be referred to the neuronal layers of 
the cortex. In real-time mode, we could observe 
pulsation of the meninges and the cortex 
synchronous with the heart beat and independent 
of blood flow. This pulsation was more evident at 
the level of the meninges, but it was also 
appreciable at the level of the layers of the cortex 
and it was not accompanied by any type of flow. In 
addition to these findings, we observed that the 
subject undergoing the procedure experienced a 
series of changes that might prove potentially 
useful in the treatment of ME/CFS. In particular, 
we observed a decrease of tachycardia 
accompanied by an increase in systolic blood 
pressure and by a significant increase in muscle 
strength measured by the degree of muscle fibre 
shortening at the level of the biceps brachii. These 
findings, together with the low cost and simplicity 
of the procedure, suggest that modified 
transcranial sonography has a significant potential 
in the study and treatment of ME/CFS. 
 
  
Journal of IiME    Volume 6  Issue 1 (June 2012) 
Invest in ME (Charity Nr. 1114035)                                        www.investinme.org  Page 24 of 108 
Introduction 
Myalgic Encephalomyelitis/Chronic Fatigue 
Syndrome (ME/CFS) designates a clinical condition 
characterized by a complex simptomatology that 
includes, but is not limited to, long-lasting 
disabling fatigue. According to the most recent 
classification, it is considered a neurological 
disease in the World Health Organization’s 
International Classification of Diseases (ICD G93.3) 
and it is characterized by widespread 
inflammation and multisystemic neuropathology 
(1). As of today, the aetiology of ME/CFS is 
unknown and, just like in any syndrome, it is quite 
likely that there may be multiple causes leading to 
a shared clinical picture. Several events may act as 
triggers, from external environmental or 
microbiological triggers, such as chemical 
exposure or infections, to psychological and social 
factors that may be critical in perpetuating the 
symptoms (2). It is worth noting that from the 
point of view of evolution of the human brain, 
ME/CFS may be defined as a “phylogenic disease” 
(3-7), according to principle of “integrated 
phylogeny” of the primate brain (8), because of its 
possible relation to evolution. 
 
For patients as well as for health care 
professionals, the issue of treatment of ME/CFS is 
a truly dramatic and controversial one. In fact, 
proposed treatments are as diverse as cognitive 
behavioral interventions (9), coiling dragon 
needling and moving cupping on back (10), 
treatment with Lactobacillus acidophilus (11), or 
with antipsychotics (12), just to name a few of the 
most recent studies. 
 
Oddly enough, among the variety of proposed 
treatments for ME/CFS, the application of 
transcranial ultrasounds by means of a common 
ultrasound imaging machine has not been 
evaluated so far. A search of the literature 
revealed that transcranial sonography had been 
used as a diagnostic tool only in one study 
describing cerebral and systemic hemodynamic 
changes during upright tilt in CFS (13). However, in 
that study, the Authors were focussed on 
observation of the middle cerebral artery using 
transcranial doppler monitoring, and did not use 
probes and techniques able to study in detail the 
cerebral cortex with particular reference to the 
gray matter of the temporal lobe. Based on our 
background in clinical radiology and anatomy, we 
were interested in studying the cerebral cortex of 
the temporal lobe because of the well known 
involvement of the temporal lobe in the 
processing of functions, such as semantics and 
memory, that are often compromised in ME/CFS 
patients (14). To this end, we modified the 
conventional procedure for transcranial 
sonography and we used a linear probe that is 
normally used for muscle-skeletal ultrasound 
imaging. To our surprise, we observed that not 
only such a procedure allowed detailed 
visualization of the cortex of the temporal lobe, a 
finding potentially important for the diagnosis and 
follow-up of ME/CFS patients, but also affected 
brain function in such a way that it could be 
proposed as a safe and easy treatment for a 
variety of diseases including ME/CFS. 
 
Materials and Methods 
The ultrasounds used for imaging, also known as 
sub-thermal ultrasounds, are is considered safe 
and have been used for foetal imaging in utero, 
and virtually every part of the body, including 
brains of newborn babies through fontanelles. For 
transcranial sonography we used an Esaote 
MyLabFive ultrasound imaging machine approved 
for many applications including cephalic (brain) 
imaging. We used the default settings for adult 
transcranial imaging, but instead of a transcranial 
probe, we used a conventional linear probe for 
muscle-skeletal examination and we selected 7.5 
MHz frequency. Acoustic power was set to 1.0. 
The length of the probe was about 4 cm, i.e. much 
less than the size of the temporal cortex that we 
examined that is 7-8 cm. The procedure was 
performed at the Laboratory for Exercise Sciences 
Applied to Medicine of the University of Firenze 
(LSMAM, Director, Prof. M. Gulisano). 
 
The volunteer healthy subject, a certified clinical 
radiologist (M.R.), sat in front of the imaging 
machine in the position he normally uses to 
perform an examination, and positioned the probe 
on his right temporal region in correspondence of 
the acoustic window of the temporal squama (Fig. 
1). An improvised support to his right arm was 
provided to ensure stability. In this position, the 
subject was able to look at his own brain while 
performing the examination. Heart rate was 
recorded 10 min prior to the transcranial 
sonography procedure, immediately before, 
during the procedure at intervals of 30 s, at the 
end of the procedure that lasted 10 min, and 10 
min after the end of the procedure. Systolic and 
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diastolic blood pressure were recorded 10 min 
prior to the procedure, immediately before, at the 
end of the procedure, and 10 min after the end of 
the procedure. Thickness of the biceps brachii was 
measured with the same probe, but this time with 
the conventional setting for muscle-skeletal 
examination. 
 
Results 
During 10 min transcranial sonography, no side 
effect was reported. The parameters adopted for 
visualization of the temporal cortex allowed to 
distinguish the meninges, the subarachnoidal 
space and the cortex (Fig. 2). The meninges 
appeared as a well organized array of layers of 
about 5 mm thickness. The thickness of the cortex 
(3.8 mm) led us to hypothesize that we were 
observing the temporal areas designated as TG 
and TE, i.e. those areas involved in the control of 
eye movements and balance in standing position 
(area TE), social behaviour, mood and decision 
making (area TG). It is worth remembering that 
most of these functions are altered to various 
degrees in ME/CFS patients’ symptoms (2). The 
spatial resolution and the ability to visualize 
structures of 200-300 µm size, led us to 
hypothesize that the linear structures (alternate 
gray-white stripes) parallel to the sub-arachnoidal 
space could be referred to the well known 
neuronal layers of the cortex (15). Considering the 
role of neuronal layer architecture alterations in 
neurodegenerative diseases (16), detailed study of 
these layers in ME/CFS might prove instrumental 
in diagnosis, prognosis and follow-up. With this 
type of setting and using Doppler technique, we 
could also observe arterial vascularisation of the 
meninges and pulsating arteries of less that one 
mm diameter could be easily visualized (Fig. 3).  
During transcranial sonography, we could also 
observe a peculiar pulsation of the meninges and 
of the cortex that was synchronous with the heart 
beat, but was not accompanied by any type of 
flow. This pulsation was more evident at the level 
of the meninges, but was also appreciable at the 
level of the layers of the cortex. A similar type of 
pulsation was described in 1987 by Klose et al. 
who used Magnetic Resonance Imaging to study 
the oscillation of the  cerebrospinal fluid within 
the cardiac cycle (17). We have no evidence, as 
yet, that the observed pattern of brain pulsation 
may be altered in ME/CFS patients nor that this 
observation may contribute to diagnosis or follow-
up. However, the easy reproducibility of the 
procedure as well as the absence of any 
discomfort, render this type of approach worth of 
further investigation. In fact, it was proposed that 
alteration of the so-called cranial rhythmic impulse 
might have a role in the pathogenesis of ME/CFS 
(18), and spinal fluid abnormalities are common in 
ME/CFS patients (19).  
 
Although the primary goal of our research was to 
set up a technique to study brain morphology and 
function in ME/CFS patients, while performing 
transcranial sonography with the indicated setting, 
we noticed that some notable changes happened 
in the subject who was at the same time the 
operator of the echo machine and the object of 
observation. In fact, an ill-defined feeling of 
strength and well-being that had been reported 
during the first measures prompted us to further 
investigate whether the ultrasounds used for 
imaging could somehow affect brain function. The 
use of transcranial ultrasounds in both military 
and civilian settings to stimulate the central 
nervous system has been recently proposed 
(http://www.darpa.mil/Opportunities/Universities
/Young_Faculty_Award_Recipients.aspx) (20), and 
a preliminary study performed at the University of 
Arizona demonstrated that transcranial ultrasound 
stimulation improved mood and increased heart 
rate, systolic and diastolic pressure and decreased 
oxygen saturation 
(http://www.quantumconsciousness.org/docume
nts/ATUS201101634A.pdf ). In the study reported 
above, however, transcranial ultrasound 
application was performed by an operator and the 
subject being investigated did not look at his own 
brain while performing the procedure. This 
difference might be significant because of the 
ensuing bio-feedback, an effect that has proven 
effective in a variety of conditions from 
neurological disorders to cancer (21, 22).  
 
In our study, we observed that heart rate 
significantly decreased from 81 beats per minute 
(bpm) at the beginning of the procedure to 71 
bpm at the end of the procedure, to 70 bpm 10 
min after the end of the procedure. Systolic blood 
pressure increased from 115 mm/Hg (10 min 
before the procedure) to 125 mm/Hg (10 min after 
the end of the procedure). Unlike the study 
quoted above, diastolic pressure did not change 
and remained constant at 75 mm/Hg before and 
after the procedure. It is well assessed that 
cardiovascular symptoms and hypotension are 
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common in ME/CFS patients (23), and it has been 
suggested that hypotension associated with 
orthostatic stress may impair neurocognitive 
functioning in ME/CFS patients with postural 
tachycardia syndrome (24). Therefore, our results 
as well as those presented by Hameroff et al. 
(http://www.quantumconsciousness.org/docume
nts/ATUS201101634A.pdf) may lead to 
interventional applications of transcranial 
sonography in the treatment of orthostatic 
intolerance, one of the major symptoms of 
ME/CFS. 
 
The observed increase in systolic blood pressure in 
the absence of a concomitant increase in heart 
rate or diastolic pressure, is of particular 
significance for ME/CFS, and it can be interpreted 
as if transcranial sonography was associated with 
increased cardiac output; in particular, as if it 
increased the stroke volume, an index that is 
frequently decreased in ME/CFS patients and is 
associated with the most common symptoms 
reported in ME/CFS, i.e. shortness of breath, 
dyspnea on effort, rapid heartbeat, chest pain, 
fainting, orthostatic dizziness and coldness of feet 
(23). The observed decrease in heart rate might 
also prove useful in those ME/CFS where 
tachycardia is a symptom associated with 
neurocognitive defects (25).  
 
In order to determine the anatomical correlate of 
the subjectively perceived increase in muscle 
strength, we measured by ultrasonography the 
thickness of the biceps brachii in relaxation and 
maximal contraction, before and after transcranial 
sonography (Fig. 4).Ten min before transcranial 
sonography, the thickness of the biceps increased 
from 24.9 mm (Fig. 4, panel A) to 38.3 mm during 
maximal contraction (Fig. 4, panel B). Ten min 
after the end of the procedure, the thickness of 
the biceps increased from 24.9 mm (Fig. 4, panel 
C) to 43.2 mm (Fig. 4, panel B). The increase in 
thickness was accompanied by a concomitant 
increase in the angle between the muscle fibres 
and the muscle aponeurosis. These results 
demonstrate that the subjectively perceived 
increase in muscle strength was indeed associated 
with a measurable increase in the capacity of the 
muscle to contract with significant increase in 
muscle fibre shortening. 
 
 
 
Discussion 
The results presented in this study raise the 
possibility of using transcranial sonography as a 
tool for the diagnosis, follow-up and treatment of 
ME/CFS patients. In recent years the cost of 
ultrasound imaging machines is significantly 
decreased and a good quality apparatus is now 
sold (in the year 2012) for about 20.000,00 Euros. 
In the hands of properly trained health care 
professionals the procedure of transcranial 
sonography described here can be used for the 
study of brain pulsations and/or rhythmic impulses 
and for the study of vascularisation of the 
meninges. Furthermore, considering that 
significant neuroanatomical changes occur in 
ME/CFS, and that these changes are consistent 
with impaired memory (26), transcranial 
sonography may prove a simple and inexpensive 
tool to assess these changes and monitor 
progression of the disease as well as 
improvements associated with treatments. The 
inherent safety of the technique as well as the 
absence of discomfort make this procedure quite 
acceptable by patients and this characteristics may 
prompt extensive studies on a significant number 
of patients.  
In addition to its use a tool contributing to 
diagnosis and follow-up, our results suggest that 
transcranial sonography may also prove useful in 
controlling some of the most disturbing symptoms 
of ME/CFS, i.e. chronic pain and mood alterations 
as demonstrated by Hameroff et al. 
((http://www.quantumconsciousness.org/docume
nts/ATUS201101634A.pdf), hypotension, 
tachycardia and muscle weakness. 
 
Figure legends 
 
Figure 1. The operator (M.R.) applying the probe 
to his right temporal region. Sitting in front of the 
ultrasound imaging machine, the operator is able 
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to observe his own brain in real time. In this way it 
is possible to observe brain pulsations as well as 
blood flow through meningeal arteries. We 
hypothesize that direct observation of the brain 
triggers a bio-feedback effect. 
 
 
Figure 2.  
Two dimension image of the temporal region. The 
skin layers and the temporal muscle are clearly 
visible. The temporal squama appears as an hyper-
reflecting (white) irregular line of about 1.4 mm 
thickness. The meninges appear as a well 
organized array of layers of about 5 mm thickness. 
The sub-arachnoidal space (white arrow) is 
identified by two hyper-reflecting (white) lines 
sandwiching an hypo-reflecting (black) space 
containing liquor. The size of the sub-arachnoidal 
space was about 0.6 mm. The neuronal layers of 
the temporal cortex (3.8 mm thickness) appear as 
alternate layers of hyper- and hypo-reflecting 
structures. The thickness of the cortex 
corresponds to that of the TE and TG areas. 
 
 
Figure 3. Pulsating arterial blood vessels in the 
meninges. 
 
 
Figure 4.  
Two dimension image of the left biceps brachii. 
Also in this case the operator applied the probe to 
his own biceps.  
A. Thickness of the relaxed biceps 10 min before 
the procedure; 24.9 mm. 
B. Thickness of the contracted biceps 10 min 
before the procedure; 38.3 mm. 
C. Thickness of the relaxed biceps 10 min after the 
procedure; 24.9 mm. Please notice; this image is 
not the same shown in panel A, as clearly visible 
looking at the orientation of the fibres. 
Nevertheless, the measurement is identical, thus 
demonstrating the reproducibility of the 
procedure. 
D. Thickness of the contracted biceps 10 min after 
the procedure; 43.2 mm. 
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ME COMMENT 
 
“Respondents found the least helpful and most 
harmful interventions were Graded Exercise 
Therapy and Cognitive Behavioural Therapy”  
Norfolk and Suffolk ME Patient Survey 2009 
http://www.norfolkandsuffolk.me.uk/surveylink.
html   
